Image

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Recruiting
25-50 years
Female
Phase N/A

Powered by AI

Overview

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.

For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Eligibility

Inclusion Criteria:

  • Female patients aged 25-50 years
  • Literate and able to comprehend written and spoken instructions
  • Diagnosed with relapsing-remitting form of multiple sclerosis
  • Having a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score ≤ 5
  • At least 3 months since the last relapse
  • Sexually active within the past 3 months
  • Spasticity level < grade 2 according to the Modified Ashworth Scale

Exclusion Criteria:

  • Pregnancy
  • Illiteracy or inability to understand spoken or written instructions
  • Absence of a continuous/regular sexual partner
  • Expanded Disability Status Scale (EDSS) score > 5
  • Not sexually active within the past 3 months
  • Spasticity level ≥ grade 2 according to the Modified Ashworth Scale

Study details
    Multiple Sclerosis
    Multiple Sclerosis (MS) - Relapsing-remitting
    Fatigue in Multiple Sclerosis
    Sexual Disfunction
    Cognitive Dysfunction
    Depression
    Anxiety
    Overactive Bladder
    Fatigue

NCT07193823

Ege University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.